• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » September-October 2019 (Volume 20, Number 5) : PDF
September-October 2019 (Volume 20, Number 5) : PDF

September-October 2019 (Volume 20, Number 5) : PDF

$59.00

Product Details

Proof is in the planning for adaptive clinical trial designs
Adaptive clinical trial design has been making its way from oncology and other specialty fields into the broader world of pharmaceutical and biologic studies. While adaptive design can offer many benefits for clinical investigators and sponsors, those conducting such trials can be easily tripped up in two areas: adequate, detailed planning of the design; and data control during the interim analysis that is the hallmark of adaptive design.

How to retain enrolled study subjects and ensure compliance
Clinical trials spend a lot of time on recruiting, screening, enrolling and initiating the right study subjects, but the way a trial works with those subjects also plays a large — and often overlooked — part in its success.

  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing